Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

Che-Yi Chang,1,2,* Ming-Chen Wang,2,* Takuya Miyagawa,1 Zhi-Yu Chen,1 Feng-Huei Lin,3,4 Ko-Hua Chen,5,6 Guei-Sheung Liu,7 Ching-Li Tseng1 1Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, 2Department of Biomedic...

Full description

Bibliographic Details
Main Authors: Chang CY, Wang MC, Miyagawa T, Chen ZY, Lin FH, Chen KH, Liu GS, Tseng CL
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:International Journal of Nanomedicine
Subjects:
RGD peptide
epigallocatechin gallate (EGCG)
hyaluronic acid (HA)
vascular endothelial cells
anti-angiogenesis
corneal neovascularization
Online Access:https://www.dovepress.com/preparation-of-argininendashglycinendashaspartic-acid-modified-biopoly-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/preparation-of-argininendashglycinendashaspartic-acid-modified-biopoly-peer-reviewed-article-IJN

Similar Items